Literature DB >> 18651432

Obesity and adiponectin in acute myocardial infarction.

Katarzyna Piestrzeniewicz, Katarzyna Luczak, Jan Komorowski, Marek Maciejewski, Monika Piechowiak, Joanna Jankiewicz-Wika, Jan Henryk Goch.   

Abstract

BACKGROUND: Low plasma concentration of adiponectin, a hormone-like peptide secreted by adipose tissue, is detected in obesity and in coronary artery disease. The aim of the study was to assess the impact of obesity on adiponectin and the relation of adiponectin to the anthropometric parameters and cardiovascular risk factors in men with acute myocardial infarction.
METHODS: Two groups of patients with first acute myocardial infarction were analyzed: 40 obese and 40 non-obese men. Waist and hip circumferences and waist-to-hip ratio, C-reactive protein (CRP), uric acid, fasting glucose, lipid profile and adiponectin were measured.
RESULTS: Mean level of adiponectin was significantly lower in obese than non-obese patients (6.80 mug/ml +/- 4.31 vs. 11.18 mug/ml +/- 7.19; p < 0.01). Adiponectin levels correlated negatively with all anthropometric measurements, the most significantly with waist circumference, with systolic blood pressure, fasting glucose, triglyceride levels, CRP, uric acid and positively with age and HDL-cholesterol. Adiponectin level was significantly associated with HDL-cholesterol, waist circumference and with trigliceryde levels and these independent variables explained 39% of the plasma adiponectin variability.
CONCLUSIONS: In patients with acute myocardial infarction obesity is related to decreased adiponectin. Low adiponectin level is associated with atherogenic lipid profile and higher levels of inflammatory markers. (Cardiol J 2007; 14: 29-36).

Entities:  

Year:  2007        PMID: 18651432

Source DB:  PubMed          Journal:  Cardiol J        ISSN: 1898-018X            Impact factor:   2.737


  3 in total

1.  Adiponectin reduces C-reactive protein expression and downregulates STAT3 phosphorylation induced by IL-6 in HepG2 cells.

Authors:  Haiyun Sun; Yingnan Zhang; Ping Gao; Qiang Li; Yuqian Sun; Jinchao Zhang; Changqing Xu
Journal:  Mol Cell Biochem       Date:  2010-10-27       Impact factor: 3.396

2.  Associations between ADIPOQ polymorphisms and coronary artery disease: a meta-analysis.

Authors:  Xia Zhang; Yan Jun Cao; Hong Yu Zhang; Hongliang Cong; Jian Zhang
Journal:  BMC Cardiovasc Disord       Date:  2019-03-18       Impact factor: 2.298

3.  Effects of ADIPOQ polymorphisms on individual susceptibility to coronary artery disease: a meta-analysis.

Authors:  Zhiyuan Wang; Jinglan Diao; Xin Yue; Jingquan Zhong
Journal:  Adipocyte       Date:  2019-03-24       Impact factor: 4.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.